Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9664382 | 0.81 | IDO1 (0.37) | LMNA | |
| SCHEMBL514918 | 0.78 | TP53 (0.50) | TP53LMNAKDM4EALDH1A1GGPS1 | |
| SCHEMBL29407957 | 0.78 | TP53 (0.50) | TP53LMNAKDM4EALDH1A1GGPS1 | |
| SCHEMBL13865816 | 0.77 | PABPC1 (0.44) | LMNAKDM4EALDH1A1GGPS1 | |
| Trifluoromethanesulfonic Acid SCHEMBL30330624 | 0.75 | KCNH2 (0.40) | TP53KDM4EALDH1A1 | |
| SCHEMBL4065869 | 0.75 | TP53 (0.46) | TP53LMNAKDM4E | |
| SCHEMBL12060359 | 0.74 | FDPS (0.54) | GGPS1 | |
| SCHEMBL18538799 | 0.73 | TP53 (0.44) | TP53LMNAKDM4E | |
| SCHEMBL3179536 | 0.73 | KDM4E (0.53) | KDM4E | |
| Fluoride Ion SCHEMBL30330321 | 0.73 | TP53 (0.44) | TP53LMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7534509-B2 | Ambient-temperature molten salts and process for producing the same | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2009-05-19 | — | — | US | disclosed |
| US-20070203345-A1 | Ambient-temperature molten salts and process for producing the same | TOYOTA JIDOSHA KABUSHIKI KAISHA | 2007-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203345-A1 | Ambient-temperature molten salts and process for producing the same | AFF1, AFF2, AFF4 | TP53 3405/4885LMNA 3669/4885KDM4E 3401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.